ISSN 1300-1868
 

Original Research (Original Article) 


A Location of Turkey among the European Union Countries in Terms of Inclusive Growth and Health Outcome Indicators

Songül ÇINAROĞLU.

Abstract
Inclusive growth and health outcomes improvement constitute main drivers of sustainable economic growth and development. This study examines the location of Turkey among the member of European Union (EU) countries in terms of inclusive growth and health outcome indicators. For this aim, inclusive economic growth indicators, that are consist of six dimensions of World Governance Indicators, belongs to the World Bank and two different health outcome indicators are used, for 28 EU countries and Turkey. Study variables are examined for two different periods, and the location of Turkey among EU countries analyzed by using hierarchical cluster analysis, for the periods of 2002-2007 and 2008-2016, which are called “high-quality” and “low-quality” economic growth, respectively. Clustering results shows that, the position of Turkey is next to the EU countries, which are good in terms of inclusive growth and health outcome indicators and representing root and old members of the EU for the period of 2002-2007; however it is far away from these countries for the period of 2008-2016. Study results emphasize that, it is incontrovertible that Turkey should internalize a policy and implementation culture of giving priority to transparency and accountability, pro-poor growing, improving employment and productivity, encouraging technology and innovation, prioritizing improvement of health status of the population, to achieve similar location with EU countries which have developed economies and have high welfare status.

Key words: Inclusive growth, health outcome indicators, European Union, Turkey, hierarchical cluster analysis. JEL Codes: O1, H5, J5, O5, C3



Kapsayıcı Büyüme Ve Sağlık Sonuç Göstergeleri Bakımından Türkiye’nin Avrupa Birliği Ülkeleri İçindeki Yeri

Ozet
Kapsayıcı büyüme ve sağlık sonuçlarının iyileştirilmesi, sürdürülebilir ekonomik büyüme ve kalkınmanın temelini oluşturmaktadır. Bu çalışma Türkiye’nin kapsayıcı büyüme ve sağlık sonuç göstergeleri bakımından Avrupa Birliği (AB)’ne üye ülkeler içindeki konumunu incelemektedir. Bu amaçla, 28 AB ülkesi ve Türkiye için Dünya Bankası’na ait Dünya Yönetişim Göstergeleri’nin altı boyuttan oluşan kapsayıcı ekonomik büyüme göstergeleri ile, iki farklı değişkenden meydana gelen sağlık sonuç göstergeleri kullanılmıştır. Çalışma değişkenleri, Türkiye’de ekonomik büyümenin sırası ile “kaliteli” ve “kalitesiz” olarak nitelendirildiği 2002-2007 ile 2008-2016 dönemleri için ayrı ayrı ele alınarak, iki ayrı dönem için Türkiye’nin AB ülkeleri içindeki yeri hiyerarşik kümeleme analizi kullanılarak belirlenmiştir. Kümeleme sonuçları, 2002-2007 dönemi itibariyle Türkiye’nin kapsayıcı büyüme ve sağlık sonuç göstergeleri bakımından iyi durumda olan, AB’nin temelini oluşturan eski üyelere yakın bir konumda yer aldığını, 2008-2016 dönemi için ise bu ülkelerden uzaklaştığını göstermektedir. Çalışma sonuçları, Türkiye’nin gelişmiş ekonomi ve refah düzeyine sahip AB ülkeleri ile benzer konuma erişebilmesi için; şeffaflık ve hesap verilebilirliğe önem veren, yoksul yanlısı büyüyen, istihdam ve verimliliği artırıcı, teknoloji ve inovasyonu teşvik eden, toplumda sağlık statüsünün yükseltilmesini önceleyen bir politika ve uygulama kültürünü benimsemesi gereğinin yadsınamaz olduğuna vurgu yapmaktadır.

Anahtar Kelimeler: Kapsayıcı büyüme, sağlık sonuç göstergeleri, Avrupa Birliği, Türkiye, hiyerarşik kümeleme analizi. JEL Kodları: O1, H5, J5, O5, C3


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Songül ÇINAROĞLU
on Google
on Google Scholar
Article Statistics
 Viewed: 1336
Downloaded: 55
Cited: 0


REFERENCES
1. Khalidi N, Ajmani H, Varga J. Coexisting Systemic Lupus Erythematosus and Sickle Cell Disease – a diagnostic and therapeutic challenge. J Clin Rheumatol 2005;11:86-92. [DOI via Crossref]    [Pubmed]   
2. Alkindi S, Al-Maini M, Pathare A. Clinical and laboratory characteristics of patients with sickle cell and autoimmune/connective tissue diseases. Rheumatol int 2012;32:373-378. [DOI via Crossref]    [Pubmed]   
3. Appenzeller S, Fattori A, Saad S, Costallat L. Systemic lupus erythematosus in patients with sickle cell disease. Clin Rheumatol 2008;27:359-364. [DOI via Crossref]    [Pubmed]   
4. Eissa MM, Lawrence JM, McKenzie L, Little FM, Mankad VN, Yang YM. Systemic lupus erythematosus in a child with sickle cell disease. Southern Medical Journal 1995;88:1176-1178. [DOI via Crossref]    [Pubmed]   
5. Saxena V, Mina R, Moallem H, Rao Sreedhar, Miller S. Systemic lupus erythematosus in children with sickle cell disease. Journal of Pediatric Hematology/Oncology 2003;25:668-671. [DOI via Crossref]    [Pubmed]   
6. Michel M, Habibi A, Godeau B, Bachir D, Lahary A, Galacteros F et al. Characteristics and Outcome of connective tissue diseases in patients with sickle cell disease: report of 30 cases. Semin Arthritis Rheum 2008;38:228-240. [DOI via Crossref]    [Pubmed]   
7. Ogunbiyi A.O, George A.O, Brown O, Okafor B.O. Diagnostic and treatment difficulties in systemic lupus erythematosus coexisting with sickle cell disease. WAJM 2007; 26:152-155.
8. Moyssakis I, Tektonidou M, Vasilliou V, Samarkos M, Votteas V, Moutsopoulos H. Libman-Sacks Endocarditis in Systemic Lupus Erythematosus: Prevalence, Associations, and Evolution. Am J Med 2007;120:636-642. [DOI via Crossref]    [Pubmed]   
9. Hession M, Au S, Gottlieb A. Parvovirus B19-associated systemic lupus erythematosus: clinical mimicry or autoimmune induction? J Rheumatol 2010;37:2430-2432 [DOI via Crossref]    [Pubmed]   
10. Isa A, Lundqvist A, Lindblom A, Tolfvenstam T, Broliden K. Cytokine responses in acute and persistent human parvovirus B19 infection. Clin Exp Immunol 2007;147:419-425. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
11. Tokano Y, Morimoto S, Kaneko H, Amano H, Nozawa K, Takasaki Y, et al. Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE) — relation to Th1- and Th2-derived cytokines. Clin Exp Immunol 1999;116:169-173. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
12. Aringer M, Stummvoll GH, Steiner G, Köller M, Steiner CW, Höfler E, et al. Serum interleukin-15 is elevated is elevated in systemic lupuserythematosus. Rheumatology 2001;40:876-881. [DOI via Crossref]    [Pubmed]   
13. Park S, Kim J, Ha T and Shin J. Association of Parvovirus B19 Infection with Systemic Lupus Erythematosus: Role of Th1 Predominance. J Rheumatol 2011;38:1221. [DOI via Crossref]    [Pubmed]   
14. Couillard S, Benkerrou M, Girot R, Brousse V, Ferster A, Bader-Meunier B. Steroid treatment in children with sickle-cell disease. Haematologica 2007;92:425-426. [DOI via Crossref]    [Pubmed]   

How to Cite this Article
Pubmed Style

Songul CINAROGLU. [A Location of Turkey among the European Union Countries in Terms of Inclusive Growth and Health Outcome Indicators]. Ekonomik Yaklasim. 2018; 29(109): 81-106. Turkish. doi:10.5455/ey.16702


Web Style

Songul CINAROGLU. [A Location of Turkey among the European Union Countries in Terms of Inclusive Growth and Health Outcome Indicators]. http://www.ekonomikyaklasim.org/?mno=11837 [Access: October 17, 2019]. Turkish. doi:10.5455/ey.16702


AMA (American Medical Association) Style

Songul CINAROGLU. [A Location of Turkey among the European Union Countries in Terms of Inclusive Growth and Health Outcome Indicators]. Ekonomik Yaklasim. 2018; 29(109): 81-106. Turkish. doi:10.5455/ey.16702



Vancouver/ICMJE Style

Songul CINAROGLU. [A Location of Turkey among the European Union Countries in Terms of Inclusive Growth and Health Outcome Indicators]. Ekonomik Yaklasim. (2018), [cited October 17, 2019]; 29(109): 81-106. Turkish. doi:10.5455/ey.16702



Harvard Style

Songul CINAROGLU (2018) [A Location of Turkey among the European Union Countries in Terms of Inclusive Growth and Health Outcome Indicators]. Ekonomik Yaklasim, 29 (109), 81-106. Turkish. doi:10.5455/ey.16702



Turabian Style

Songul CINAROGLU. 2018. [A Location of Turkey among the European Union Countries in Terms of Inclusive Growth and Health Outcome Indicators]. Ekonomik Yaklasim, 29 (109), 81-106. Turkish. doi:10.5455/ey.16702



Chicago Style

Songul CINAROGLU. "[A Location of Turkey among the European Union Countries in Terms of Inclusive Growth and Health Outcome Indicators]." Ekonomik Yaklasim 29 (2018), 81-106. Turkish. doi:10.5455/ey.16702



MLA (The Modern Language Association) Style

Songul CINAROGLU. "[A Location of Turkey among the European Union Countries in Terms of Inclusive Growth and Health Outcome Indicators]." Ekonomik Yaklasim 29.109 (2018), 81-106. Print.Turkish. doi:10.5455/ey.16702



APA (American Psychological Association) Style

Songul CINAROGLU (2018) [A Location of Turkey among the European Union Countries in Terms of Inclusive Growth and Health Outcome Indicators]. Ekonomik Yaklasim, 29 (109), 81-106. Turkish. doi:10.5455/ey.16702